Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-naïve, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A double-blind, randomized, phase 2 trial

Douglas R. Adkins, Makoto Tahara, Assuntina G. Sacco et al.|Oral Oncology|2021

Cited by 43